Prostanoid receptors in anagen human hair follicles

Experimental Dermatology

Volumn 17, Issue 1, 2008, Pages 63-72

  Bernard, Bruno Alain ^a   Michelet, Jean François ^a   Colombe, Laurent ^a  

^a L ORÉAL RECHERCHE   (France)

Author keywords

Follicle; Hair; Human; Prostanoid; Receptors

Indexed keywords

PROSTACYCLIN RECEPTOR; PROSTAGLANDIN D2 RECEPTOR PROTEIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROSTANOID RECEPTOR; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASEMENT MEMBRANE; CELL TYPE; CONTROLLED STUDY; FEMALE; GROWTH REGULATION; HAIR FOLLICLE; HAIR GROWTH; HAIR ROOT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BIOPSY; CELLS, CULTURED; FEMALE; HAIR FOLLICLE; HUMANS; MIDDLE AGED; RECEPTORS, EPOPROSTENOL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SCALP;

EID: 37249028593     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00639.x     Document Type: Article

References (64)

1. Kobayashi T, Narumiya SFunction of prostanoid receptors: Studies on knockout mice. Prostaglandins Other Lipid Mediat 2002: 68-69: 557-573.
2. Coleman R A, Smith W L, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994: 46: 205-229.
3. Meyer H C. Alopecia associated with ibuprofen. JAMA 1979: 242: 142.
4. Pillans P I, Woods D J. Drug-associated alopecia. Int J Dermatol 1995: 34: 149-158.
5. Michelet J F, Commo S, Billoni N, Mahe Y F, Bernard B A. Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. J Invest Dermatol 1997: 108: 205-209.
6. Di Poi N, Ng C Y, Tan N S et al. Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/ delta during hair follicle development. Mol Cell Biol 2005: 25: 1696-1712.
7. Muller-Decker K, Leder C, Neumann M et al. Expression of cyclooxygenase isozymes during morphogenesis and cycling of pelage hair follicles in mouse skin: Precocious onset of the first catagen phase and alopecia upon cyclo-oxygenase-2 overexpression. J Invest Dermatol 2003: 121: 661-668.
8. Bol D K, Rowley R B, Ho C P et al. Cyclo-oxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. Cancer Res 2002: 62: 2516-2521.
9. Colombe L, Vindrios A, Michelet J F, Bernard B A. Prostaglandin metabolism in human hair follicle. Exp Dermatol 2007: 16: 762-769.
10. Kabashima K, Miyachi Y. Prostanoids in the cutaneous immune response. J Dermatol Sci 2004: 34: 177-184.
11. Johnstone M A. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997: 124: 544-547.
12. Johnstone M A, Albert D M. Prostaglandin-induced hair growth. Surv Ophthalmol 2002: 47 (Suppl. 1): S185-S202.
13. Stjernschantz J W. From PGF(2alpha)-isopropyl ester to latanoprost: A review of the development of xalatan: The Proctor Lecture. Invest Ophthalmol Vis Sci 2001: 42: 1134-1145.
14. Sasaki S, Hozumi Y, Kondo S. Influence of prostaglandin F2α and its analogues on hair regrowth and follicular melanogenesis in a murine model. Exp Dermatol 2005: 14: 323-328.
15. Uno H, Zimbric M L, Albert D M, Stjernschantz J. Effect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: A pilot study. Acta Derm Venereol 2002: 82: 7-12.
16. Commo S, Gaillard O, Thibaut S, Bernard B A. Absence of TRP-2 in melanogenic melanocytes of human hair. Pigment Cell Res 2004: 17: 488-497.
17. Rheinwald J G, Green H. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 1975: 6: 331-343.
18. Messenger A G. The culture of dermal papilla cells from human hair follicles. Br J Dermatol 1984: 110: 685-689.
19. Schlotzer-Schrehardt U, Zenkel M, Nusing R M. Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest Ophthalmol Vis Sci 2002: 43: 1475-1487.
20. Kyveris A, Maruscak E, Senchyna M. Optimization of RNA isolation from human ocular tissues and analysis of prostanoid receptor mRNA expression using RT-PCR. Mol Vis 2002: 8: 51-58.
21. Nagata K, Tanaka K, Ogawa K et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 1999: 162: 1278-1286.
22. Scott G, Leopardi S, Printup S et al. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: Analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity. J Invest Dermatol 2004: 122: 1214-1224.
23. Arbab F, Goldsby J, Matijevic-Aleksic N et al. Prostacyclin is an autocrine regulator in the contraction of oviductal smooth muscle. Hum Reprod 2002: 17: 3053-3059.
24. Konger R L, Billings S D, Thompson A B et al. Immunolocalization of low-affinity prostaglandin E receptors, EP and EP, in adult human epidermis. J Invest Dermatol 2005: 124: 965-970.
25. Lee J L, Kim A, Kopelovich L, Bickers D R, Athar M. Differential expression of E prostanoid receptors in murine and human nonmelanoma skin cancer. J Invest Dermatol 2005: 125: 818-825.
26. Muller K, Krieg P, Marks F, Furstenberger G. Expression of PGF(2α) receptor mRNA in normal, hyperplastic and neoplastic skin. Carcinogenesis 2000: 21: 1063-1066.
27. Kabashima K, Sakata D, Nagamachi M et al. Prostaglandin E2- EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 2003: 9: 744-749.
28. Tsuboi K, Sugimoto Y, Ichikawa A. Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat 2002: 69: 535-556.
29. Verbeuren T J. Terutroban and endothelial TP receptors in atherogenesis. Med Sci (Paris) 2006: 22: 437-443.
30. Vanderveen E E, Grekin R C, Swanson N A, Kragballe K. Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. Arch Dermatol 1986: 122: 407-412.
31. Downard C D, Roberts L J, Morrow J D. Topical benzoic acid induces the increased biosynthesis of prostaglandin D2 in human skin in vivo. Clin Pharmacol Ther 1995: 57: 441-445.
32. Massey W A, Hubbard W C, Liu M C et al. Profile of prostanoid release following antigen challenge in vivo in the skin of man. Br J Dermatol 1991: 125: 529-534.
33. Ziboh V A. Prostaglandins, leukotrienes, and hydroxy fatty acids in epidermis. Semin Dermatol 1992: 11: 114-120.
34. Futaki N, Arai I, Sugimoto M et al. Role of prostaglandins on mechanical scratching-induced cutaneous barrier disruption in mice. Exp Dermatol 2007: 16: 507-512.
35. Han C, Wu T. Cyclo-oxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem 2005: 280: 24053-24063.
36. Watanabe M, Ishiwata T, Nishigai K, Moriyama Y, Asano G. Overexpression of keratinocyte growth factor in cancer cells and enterochromaffin cells in human colorectal cancer. Pathol Int 2000: 50: 363-372.
37. Kawamori T, Kitamura T, Watanabe K et al. Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development. Carcinogenesis 2005: 26: 353-357.
38. Ma X, Kundu N, Rifat S, Walser T, Fulton A M. Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis. Cancer Res 2006: 66: 2923-2927.
39. Thompson E J, Gupta A, Vielhauer G A, Regan J W, Bowden G T. The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1. Neoplasia 2001: 3: 402-410.
40. Tober K L, Wilgus T A, Kusewitt D F et al. Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development. J Invest Dermatol 2006: 126: 205-211.
41. Sylvia V L, Del T F Jr, Hardin R R et al. Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D(3) effects on growth zone chondrocytes. J Steroid Biochem Mol Biol 2001: 78: 261-274.
42. Sung Y M, He G, Fischer S M. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development. Cancer Res 2005: 65: 9304-9311.
43. Huang S, Wettlaufer S H, Hogaboam C, Aronoff D M, Peters- Golden M. Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol 2007: 292: L405-L413.
44. Konger R L, Brouxhon S, Partillo S, VanBuskirk J, Pentland A P. The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes. Exp Dermatol 2005: 14: 914-922.
45. Hawcroft G, Ko C W, Hull M A. Prostaglandin E(2)-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells. Oncogene 2006: 26: 3006-3019.
46. Mutoh M, Takahashi M, Wakabayashi K. Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention. Curr Pharm Des 2006: 12: 2375-2382.
47. Miyamoto M, Ito H, Mukai S et al. Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. Osteoarthritis Cartilage 2003: 11: 644-652.
48. Torii E, Segi E, Sugimoto Y et al. Expression of prostaglandin E(2) receptor subtypes in mouse hair follicles. Biochem Biophys Res Commun 2002: 290: 696-700.
49. Hu D N, McCormick S A, Woodward D F. A functional study on prostanoid receptors involved in cultured human iridal melanocyte stimulation. Exp Eye Res 2001: 73: 93-100.
50. Honma Y, Arai I, Hashimoto Y et al. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. Eur J Pharmacol 2005: 518: 56-62.
51. Kapoor M, Kojima F, Yang L, Crofford L J. Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators- activated receptor-gamma during normal wound healing: A time course study. Prostaglandins Leukot Essent Fatty Acids 2007: 76: 103-112.
52. Commo S, Gaillard O, Bernard B A. The human hair follicle contains two distinct K19 positive compartments in the outer root sheath: A unifying hypothesis for stem cell reservoir? Differentiation 2000: 66: 157-164.
53. Billoni N, Buan B, Gautier B et al. Expression of peroxisome proliferator activated receptors (PPARs) in human hair follicles and PPAR alpha involvement in hair growth. Acta Derm Venereol 2000: 80: 329-334.
54. Wise H. Multiple signalling options for prostacyclin. Acta Pharmacol Sin 2003: 24: 625-630.
55. Gu L H, Coulombe P A. Keratin expression provides novel insight into the morphogenesis and function of the companion layer in hair follicles. J Invest Dermatol 2007: 127: 1061-1073.
56. Sugimoto Y, Yamasaki A, Segi E et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997: 277: 681-683.
57. Roenigk H H Jr. New topical agents for hair growth. Clin Dermatol 1988: 6: 119-121.
58. Yano K, Brown L F, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 2001: 107: 409-417.
59. Hanai Y, Tokuda H, Takai S et al. Minodronate suppresses prostaglandin F2α-induced vascular endothelial growth factor synthesis in osteoblasts. Horm Metab Res 2006: 38: 152-158.
60. Sales K J, List T, Boddy S C et al. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res 2005: 65: 7707-7716.
61. Mecklenburg L, Tobin D J, Muller-Rover S et al. Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol 2000: 114: 909-916.
62. Scott G, Jacobs S, Leopardi S et al. Effects of PGF2α on human melanocytes and regulation of the FP receptor by ultraviolet radiation. Exp Cell Res 2005: 304: 407-416.
63. Legler D F, Krause P, Scandella E, Singer E, Groettrup M. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J Immunol 2006: 176: 966-973.
64. Spik I, Brenuchon C, Angeli V et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J Immunol 2005: 174: 3703-3708.